Their multicenter retrospective analysis revealed that a preoperative low albumin-to-fibrinogen ratio (AFR) serves as a prognostic biomarker for poorer time to progression (TTP), overall survival (OS), and cancer-specific survival (CSS). Here, ALB is linked to cancer.